Estimation of Out-of-Pocket Costs for Guideline-Directed Medical Therapy for Heart Failure Under Medicare Part D and the Inflation Reduction Act.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.5033
Abstract: This cross-sectional study estimates out-of-pocket costs of heart failure with reduced ejection fraction medication regimens in Medicare Part D under current law and the Inflation Reduction Act. read more here.
Keywords: medicare part; heart failure; inflation reduction; reduction act ... See more keywords
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2021.7457
Abstract: Importance Most adults 65 years or older have multiple chronic conditions. Managing these conditions with prescription drugs can be costly, particularly for older adults with limited incomes. Objective To estimate hypothetical out-of-pocket costs associated with… read more here.
Keywords: medicare; older adults; pocket; guideline recommended ... See more keywords
Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.3946
Abstract: Importance Rising drug costs contribute to medication nonadherence and adverse health outcomes. Real-time prescription benefit (RTPB) systems present prescribers with patient-specific out-of-pocket cost estimates and recommend lower-cost, clinically appropriate alternatives at the point of prescribing.… read more here.
Keywords: prescription; cost; trial; patient pocket ... See more keywords
Trends in Well-Child Visits With Out-of-Pocket Costs in the US Before and After the Affordable Care Act
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.1248
Abstract: This cross-sectional study uses national claims data to assess trends in well-child care visits with out-of-pocket costs before and after passage of the Affordable Care Act. read more here.
Keywords: pocket costs; care act; trends well; affordable care ... See more keywords
Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.31475
Abstract: This cross-sectional study evaluates the association of generic competition and changes in product coverage and cost-sharing by using Medicare data and estimated out-of-pocket costs for the oral specialty drug abiraterone. read more here.
Keywords: coverage; abiraterone; evaluation medicare; estimated pocket ... See more keywords
Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.54590
Abstract: This cross-sectional study evaluates trends in out-of-pocket costs for and characteristics of pharmacy-dispensed buprenorphine medications for opioid use disorder treatment by type of payer from 2015 to 2020. read more here.
Keywords: dispensed buprenorphine; characteristics pharmacy; costs characteristics; pharmacy dispensed ... See more keywords
Out-of-Pocket Costs of Treatment Among Employer-Insured Women With Invasive Breast Cancer
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.1507
Abstract: This cross-sectional study examines out-of-pocket costs for the treatment of invasive breast cancer in employer-insured women younger than 65 years. read more here.
Keywords: employer insured; invasive breast; insured women; costs treatment ... See more keywords
Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients.
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2020.12.015
Abstract: OBJECTIVE To evaluate total and out-of-pocket costs for poly(ADP-ribose) polymerase (PARP) inhibitors and differences based on insurance characteristics. METHODS We identified ovarian cancer patients who were prescribed niraparib, olaparib, or rucaparib from the MarketScan (2014-2017)… read more here.
Keywords: parp inhibitors; pocket costs; ovarian cancer; total pocket ... See more keywords
Variations in out-of-pocket costs for primary care services across Australia: a regional analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Australian journal of primary health"
DOI: 10.1071/py16127
Abstract: The aim of this study is to describe average out-of-pocket costs across different regions of Australia, as defined by Primary Health Network (PHN) boundaries, and assess the association between population characteristics and out-of-pocket costs for… read more here.
Keywords: pocket costs; primary care; care services; health ... See more keywords
A National Perspective of Telemedicine Use and Direct Medical Costs: Who Uses it and How Much it Costs.
Sign Up to like & getrecommendations! Published in 2023 at "Medical care"
DOI: 10.1097/mlr.0000000000001856
Abstract: BACKGROUND Telemedicine has the potential to reduce medical costs among health systems. However, there is a limited understanding of the use of telemedicine and its association with direct medical costs. OBJECTIVES Using nationally representative data,… read more here.
Keywords: medical costs; pocket costs; direct medical; telemedicine use ... See more keywords
Psychosocial burden and out‐of‐pocket costs in patients with atopic dermatitis in Ireland
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.14422
Abstract: Atopic dermatitis (AD) is one of the most common inflammatory skin diseases in the developed world, affecting 1–3% of the adult population in Europe. This inflammatory disease can have a marked impact on affected individuals,… read more here.
Keywords: pocket costs; costs patients; disease; atopic dermatitis ... See more keywords